TY - JOUR
T1 - Antegrade percutaneous endopyelotomy
AU - Ko, Raymond
AU - Duvdevani, Mordechai
AU - Denstedt, John D.
PY - 2007/3
Y1 - 2007/3
N2 - Ureteropelvic junction obstruction (UPJO) is a well-known pathologic condition with several potential associated urologic complications. The treatment for UPJO has evolved dramatically during the past two decades with the advent of minimally invasive treatment options. This has resulted in shorter hospital stays, reduced postoperative pain, and quicker convalescence compared with the gold standard, open pyeloplasty. Antegrade (percutaneous) endopyelotomy is one of the many minimally invasive treatment options for this disorder. In this article, we review the technical aspects, outcomes, and current role of antegrade endopyelotomy in the treatment of UPJO.
AB - Ureteropelvic junction obstruction (UPJO) is a well-known pathologic condition with several potential associated urologic complications. The treatment for UPJO has evolved dramatically during the past two decades with the advent of minimally invasive treatment options. This has resulted in shorter hospital stays, reduced postoperative pain, and quicker convalescence compared with the gold standard, open pyeloplasty. Antegrade (percutaneous) endopyelotomy is one of the many minimally invasive treatment options for this disorder. In this article, we review the technical aspects, outcomes, and current role of antegrade endopyelotomy in the treatment of UPJO.
UR - http://www.scopus.com/inward/record.url?scp=33847694017&partnerID=8YFLogxK
U2 - 10.1007/s11934-007-0062-0
DO - 10.1007/s11934-007-0062-0
M3 - Review article
C2 - 17303018
AN - SCOPUS:33847694017
SN - 1527-2737
VL - 8
SP - 128
EP - 133
JO - Current Urology Reports
JF - Current Urology Reports
IS - 2
ER -